title: How to manage no reflow phenomenon with local drug delivery via a rapid exchange catheter.
abstract: We describe two cases of no reflow phenomenon in the setting of primary PCI for ST elevation myocardial infarction successfully managed with intracoronary vasodilator therapy via a Clearway™ balloon catheter, where vasodilator therapy via the guiding catheter had been ineffective. Traditionally, if not given via the guiding catheter, vasodilators have been administered via an over-the-wire balloon catheter, which can be cumbersome and time consuming. The Clearway catheter is a rapid exchange balloon catheter affording rapid delivery of vasodilators to the distal infarct related artery without risk of loss of wire position. © 2010 Wiley-Liss, Inc.
authors.affiliation: Department of Cardiology, Royal Melbourne Hospital, Melbourne, Victoria, Australia. wmclwilson@hotmail.com
authors.forename: William
authors.initials: W
authors.lastname: Wilson
authors.forename: David
authors.initials: D
authors.lastname: Eccleston
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000295:instrumentation*; D057785:Catheters; D017023:Coronary Angiography; D004333:Drug Administration Routes; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D005996:Nitroglycerin / Q000008:administration & dosage*; D054318:No-Reflow Phenomenon / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000008:administration & dosage*; D014700:Verapamil / Q000008:administration & dosage*
chemical_list: D014665:Vasodilator Agents; D014700:Verapamil; D005996:Nitroglycerin